PERRI-CR 25 is a controlled-release tablet containing Paroxetine 25 mg. The controlled-release formulation is designed to release the active medicine gradually after administration.
Paroxetine is an SSRI that affects serotonin signalling in the nervous system. Depending on the patient’s diagnosis and medical history, a physician may prescribe paroxetine for certain psychiatric or other clinically appropriate conditions.
Because individual response and dosing requirements vary, treatment should always be supervised by a qualified doctor. The tablet should be swallowed whole and must not be crushed or chewed, as doing so may interfere with the controlled-release formulation.






Reviews
There are no reviews yet.